Glycemic Control in Elderly SNF Patients

Appropriate HbA1c Targets

• The American Geriatrics Society recommends a target HbA1c of 7.5-8.0% for elderly patients in skilled nursing facilities to balance benefits and risks 1, 3
• The American College of Physicians recommends an HbA1c target range of 7-8% for most older adults to reduce complications while avoiding adverse events 5
• Higher HbA1c targets (8-9%) are appropriate for frail older adults with multiple comorbidities, poor health, and limited life expectancy 1, 4

Risk Assessment and Management

• An HbA1c of 6.9% in an elderly SNF patient indicates potential overtreatment that increases risk of hypoglycemia 1, 5
• Tight glycemic control (HbA1c <7%) in elderly patients has not been shown to provide benefits and may cause harm 1, 6
• Consider de-escalation of diabetes therapy to allow HbA1c to rise into the 7.5-8% target range 5

Monitoring and Treatment

• For stable elderly patients with HbA1c in target range, HbA1c can be measured every 12 months 1, 4
• Metformin (if not contraindicated) and DPP-4 inhibitors are preferred agents for elderly SNF patients due to lower hypoglycemia risk 8, 7
• Assess for symptoms of hypoglycemia, which may present atypically in elderly patients (confusion, falls, weakness) 6

Important Considerations

• Avoid aggressive glycemic control in elderly SNF patients as the risk of hypoglycemia outweighs potential benefits of tight control 6, 5
• Hypoglycemia in elderly patients increases risk of falls, fractures, cognitive decline, and cardiovascular events 8
• Treatment decisions should prioritize quality of life and symptom management rather than achieving specific numeric targets 5